Nevro (NYSE: NVRO) is a public multinational medical technology company headquartered in Redwood City, California. We have developed HF10™ therapy, an innovative, evidence-based neuromodulation platform.
We started with a simple mission to help more patients suffering from chronic pain. At each stage of development, our research was subject to the highest levels of scientific rigor, resulting in a new therapy that has impacted the lives of over 36,000 patients around the world.
The Nevro® Senza® SCS System received CE mark in 2010, TGA approval in 2011, FDA approval in 2015, and is commercially available in Europe, Australia, and the United States.
The Manager Revenue Operations will lead Nevro’s global revenue accounting function. The successful candidate will lead the revenue month-end and quarter-end close procedures while ensuring adherence to internal controls. As a member of the finance team, this role will have the opportunity to lead improvements for automation and implement new processes. The successful candidate must have the ability to operate effectively in a rapidly growing and dynamic environment.